Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer revision number for the ClinicalTrials.gov page is updated from v3.5.2 to v3.5.3, reflecting a site software/release update rather than a change to the trial’s study details.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows updated last-update dates, reflecting maintenance of the record; no substantive study content appears to have changed.SummaryDifference0.2%

- Check36 days agoChange DetectedAdded the disease term 'Squamous cell carcinoma of the head and neck' to broaden the study context. Added a Resources link to the Genetic and Rare Diseases Information Center for patient information.SummaryDifference0.1%

- Check43 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedDifference0.3%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.